
Strata Critical Medical, Inc.
SRTANasdaqCIK 1779128IndustrialsFiscal year ends Dec 31
Reports and events: 109 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-05-1116:52 ET | 8-K | 5.07 Shareholder vote results | 0001779128-23-000056 |
| 2023-05-1108:51 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001779128-23-000052 |
| 2023-05-1107:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001779128-23-000049 |
| 2023-03-3117:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-23-025656 |
| 2023-03-3016:33 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-039190 |
| 2023-03-3016:30 ET | DEF 14A | Proxy statementPeriod 2023-05-09 | 0001104659-23-039182 |
| 2023-03-1618:06 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001779128-23-000029 |
| 2023-03-1407:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001779128-23-000025 |
| 2023-02-2816:06 ET | 8-K | 8.01 Other events | 0001104659-23-026703 |
| 2023-02-1321:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-018851 |
| 2023-01-1920:14 ET | SC 13D | Ownership report, active investor | 0001213900-23-003570 |
| 2023-01-1017:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001779128-23-000007 |
| 2022-11-1016:08 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001779128-22-000112 |
| 2022-11-0916:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001779128-22-000109 |
| 2022-09-0708:01 ET | 8-K | 8.01 Other events | 0001104659-22-098050 |
| 2022-08-0908:04 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001779128-22-000083 |
| 2022-08-0907:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001779128-22-000081 |
| 2022-05-1908:01 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-062713 |
| 2022-05-1007:58 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001779128-22-000047 |
| 2022-05-1007:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001779128-22-000044 |
| 2022-05-0614:26 ET | 8-K | 5.07 Shareholder vote results | 0001779128-22-000036 |
| 2022-03-2216:05 ET | DEF 14A | Proxy statementPeriod 2022-05-04 | 0001104659-22-036550 |
| 2022-02-1016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001779128-22-000020 |
| 2022-02-0216:20 ET | 8-K | 5.03 Amendment to articles or bylaws | 0001779128-22-000008 |
| 2021-12-2016:44 ET | 10-K | Annual reportPeriod 2021-09-30 | 0001779128-21-000025 |
| 2021-12-2007:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001779128-21-000016 |
| 2021-12-0208:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-145694 |
| 2021-09-2416:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-119291 |
| 2021-09-1708:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-116671 |
| 2021-09-0908:16 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-114037 |
| 2021-08-1607:04 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001104659-21-105544 |
| 2021-08-1607:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-105537 |
| 2021-05-2816:43 ET | S-1 | Registration statement | 0001104659-21-074243 |
| 2021-05-2417:01 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001104659-21-071301 |
| 2021-05-1917:22 ET | SC 13D | Ownership report, active investor | 0001193125-21-166752 |
| 2021-05-1716:56 ET | SC 13D | Ownership report, active investor | 0001104659-21-068215 |
| 2021-05-1716:44 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-068193 |
| 2021-05-1716:30 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-21-068136 |
| 2021-05-1319:55 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits | 0001104659-21-065292 |
| 2021-05-1008:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-063444 |
| 2021-05-0716:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-063108 |
| 2021-05-0706:02 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001104659-21-062658 |
| 2021-05-0606:00 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-061958 |
| 2021-04-2806:09 ET | 8-K | 4.02 Non-reliance on financial statements; 8.01 Other events | 0001104659-21-055907 |
| 2021-04-0708:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-047352 |
| 2021-03-1808:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-038100 |
| 2021-03-1006:04 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001104659-21-034054 |
| 2021-01-1110:20 ET | 8-K | 8.01 Other events | 0001104659-21-002818 |
| 2020-12-1508:51 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-135523 |
| 2020-11-1016:01 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001104659-20-123573 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 18:10 ET. Listed shows no prices and gives no investment advice.